(19)
(11) EP 3 448 408 A1

(12)

(43) Date of publication:
06.03.2019 Bulletin 2019/10

(21) Application number: 17722497.9

(22) Date of filing: 25.04.2017
(51) International Patent Classification (IPC): 
A61K 38/04(2006.01)
A61K 31/365(2006.01)
C07D 303/36(2006.01)
A61K 38/06(2006.01)
A61K 31/4015(2006.01)
A61K 38/12(2006.01)
A61K 31/69(2006.01)
A61P 35/00(2006.01)
A61K 45/06(2006.01)
(86) International application number:
PCT/GB2017/051148
(87) International publication number:
WO 2017/187156 (02.11.2017 Gazette 2017/44)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 26.04.2016 GB 201607279

(71) Applicant: Big DNA Ltd
Roslin, Midlothian EH25 9PP (GB)

(72) Inventors:
  • MARCH, John, Bernard
    Roslin Midlothian EH25 9PP (GB)
  • CLARK, Ewan, McIntosh
    Roslin Midlothian EH25 9PP (GB)

(74) Representative: HGF Limited 
1 City Walk
Leeds LS11 9DX
Leeds LS11 9DX (GB)

   


(54) COMBINATION THERAPY